SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection
Open Access
- 15 November 2022
- journal article
- research article
- Published by Elsevier in Microbes and Infection
- Vol. 25 (1-2) , 105077
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersiteCell Host & Microbe, 2021
- SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination seraCell Host & Microbe, 2021
- Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence StudiesJournal of Virology, 2021
- COVID-19-neutralizing antibodies predict disease severity and survivalCell, 2021
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severityScience, 2020
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesNature, 2020
- Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusionNature, 2020
- Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological resultsClinical Microbiology and Infection, 2020
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spikeNature, 2020
- Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease PatientsEmerging Infectious Diseases, 2020